Many investors appear to be quite bearish Spectrum Pharmaceuticals, Inc. (SPPI - Free Report)
especially if you look at the percentage of the float that is sold short for this stock. Currently, 34.4%
of the float is sold short, suggesting an extreme level of bearishness for SPPI
However, it is worth noting that earnings estimates have actually been moving higher for the company, despite the pessimism. Thanks to these rising estimates, we actually have a Zacks Rank #2 (Buy) on SPPI,
so we clearly don’t believe in the negativity surrounding this firm, and are instead looking for shares of SPPI
to move higher in the weeks ahead.